Q4 2014 13F Holders as of 12/31/2014
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
58.6M
-
Number of holders
-
144
-
Total 13F shares, excl. options
-
27.6M
-
Shares change
-
+3.02M
-
Total reported value, excl. options
-
$3.1B
-
Value change
-
+$395M
-
Put/Call ratio
-
1.32
-
Number of buys
-
89
-
Number of sells
-
-62
-
Price
-
$112.04
Significant Holders of AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (AGIO) as of Q4 2014
176 filings reported holding AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share as of Q4 2014.
AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (AGIO) has 144 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 27.6M shares
of 58.6M outstanding shares and own 47.13% of the company stock.
Largest 10 shareholders include FMR LLC (5.49M shares), Capital World Investors (3.1M shares), Third Rock Ventures, LLC (3.07M shares), WELLINGTON MANAGEMENT GROUP LLP (2.01M shares), Flagship Ventures 2007 General Partner LLC (1.93M shares), BB Biotech AG (1.86M shares), VANGUARD GROUP INC (1.29M shares), Capital International Investors (856K shares), BlackRock Fund Advisors (785K shares), and CAPITAL GUARDIAN TRUST CO (675K shares).
This table shows the top 144 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.